[Modalities of purine excretion during enzyme treatment of gout and other hyperuricemic conditions with urate oxidase]
[Article in
French]
- PMID: 5737250
Item in Clipboard
[Modalities of purine excretion during enzyme treatment of gout and other hyperuricemic conditions with urate oxidase]
[Article in
French]
Presse Med (1893).
.
No abstract available
Similar articles
-
[Treatment of gouty purine metabolism disorder with mercapto-pyrazolo-pyrimidine (thiopurinol)].Presse Med (1893). 1968 Dec 14;76(49):2329. Presse Med (1893). 1968. PMID: 5737251 French. No abstract available.
-
[Uricolytic therapy. Value of urate oxidase in the treatment of hyperuricemias].Nouv Presse Med. 1975 Apr 12;4(15):1109-12. Nouv Presse Med. 1975. PMID: 1094413 Clinical Trial. French.
-
[Experimentation with urate oxidase].J Belge Rhumatol Med Phys. 1971 Jul-Aug;26(4):169-78. J Belge Rhumatol Med Phys. 1971. PMID: 5147001 French. No abstract available.
-
Selected aspects of the aetiology, pathogenesis and treatment of disorders of purine metabolism.Mod Trends Rheumatol. 1971;2:299-322. Mod Trends Rheumatol. 1971. PMID: 4949589 Review. No abstract available.
-
Renal excretion of purine metabolites, urate and allantoin, by the mammalian kidney.Int Rev Physiol. 1976;11:257-81. Int Rev Physiol. 1976. PMID: 794013 Review. No abstract available.
Cited by
-
Production and Characterization of Recombinant Wild Type Uricase from Indonesian Coelacanth (L. menadoensis) and Improvement of Its Thermostability by In Silico Rational Design and Disulphide Bridges Engineering.Int J Mol Sci. 2019 Mar 13;20(6):1269. doi: 10.3390/ijms20061269. Int J Mol Sci. 2019. PMID: 30871218 Free PMC article.
-
Antigenic independence of some microbial urate oxidases.Infect Immun. 1975 Dec;12(6):1237-41. doi: 10.1128/iai.12.6.1237-1241.1975. Infect Immun. 1975. PMID: 812823 Free PMC article.
-
Immunological aspects of urate oxidase therapy in hyperuricaemia.Ir J Med Sci. 1977 Jun;146(6):155-61. doi: 10.1007/BF03030952. Ir J Med Sci. 1977. PMID: 608828 No abstract available.